miR-34a regulates mesangial cell proliferation via the PDGFR-β/Ras-MAPK signaling pathway

Cellular and Molecular Life Sciences

Volumn 71, Issue 20, 2014, Pages 4027-4042

  Chen, Dapeng ^a,b   Li, Ying ^c   Mei, Yan ^a   Geng, Wenjia ^a   Yang, Jurong ^d   Hong, Quan ^a   Feng, Zhe ^a   Cai, Guangyan ^a   Zhu, Hanyu ^a   Shi, Suozhu ^a   Bai, Xue Yuan ^a   Chen, Xiangmei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c HEBEI MEDICAL UNIVERSITY   (China)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Mesangial proliferative glomerulonephritis (MsPGN); miR 34a; PDGFR ; Ras MAPK signaling pathway

Indexed keywords

CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; CYCLIN E; MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RAS PROTEIN; THY 1 ANTIGEN; ALLOANTIBODY; ANTI THY ANTIBODY; ANTI-THY ANTIBODY; CELL CYCLE PROTEIN; MIRN34 MICRORNA, RAT; MITOGEN ACTIVATED PROTEIN KINASE KINASE; SMALL INTERFERING RNA;

ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MALE; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; 3' UNTRANSLATED REGION; ANIMAL; CELL CYCLE G1 PHASE; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENETICS; GLOMERULONEPHRITIS; IMMUNOLOGY; METABOLISM; PATHOLOGY; RNA INTERFERENCE; WISTAR RAT;

3' UNTRANSLATED REGIONS; ANIMALS; CELL CYCLE PROTEINS; CELL LINE; CELL PROLIFERATION; G1 PHASE; GLOMERULONEPHRITIS; ISOANTIBODIES; MESANGIAL CELLS; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; RAS PROTEINS; RATS; RATS, WISTAR; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84909999174     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-014-1599-y     Document Type: Article

References (52)

1. Cove-Smith A, Hendry BM (2008) The regulation of mesangial cell proliferation. Nephron Exp Nephrol 108:e74-e79
2. Schlondorff D, Banas B (2009) The mesangial cell revisited: no cell is an island. J Am Soc Nephrol 20:1179-1187
3. Eddy AA (2005) Progression in chronic kidney disease. Adv Chronic Kidney Dis 12:353-365
4. Kriz W, Hahnel B, Hosser H, Ostendorf T, Gaertner S, Kranzlin B, Gretz N, Shimizu F, Floege J (2003) Pathways to recovery and loss of nephrons in anti-Thy-1 nephritis. J Am Soc Nephrol 14:1904-1926
5. Ono T, Liu N, Makino T, Nogaki F, Muso E, Honda G, Kita T (2005) Suppressive mechanisms of Sairei-to on mesangial matrix expansion in rat mesangioproliferative glomerulonephritis. Nephron Exp Nephrol 100:e132-e142
6. Ikezumi Y, Kanno K, Karasawa T, Han GD, Ito Y, Koike H, Toyabe S, Uchiyama M, Shimizu F, Kawachi H (2004) The role of lymphocytes in the experimental progressive glomerulonephritis. Kidney Int 66:1036-1048
7. Wang Y, He Q, Qin H, Xu J, Tong J, Gao L, Xu J (2006) The complement C5b-9 complexes induced injury of glomerular mesangial cells in rats with Thy-1 nephritis by increasing nitric oxide synthesis. Life Sci 79:182-192
8. Wan Y, Gu L, Suzuki K, Karasawa T, Fujioka Y, Han GD, Koike H, Kawachi H, Shimizu F (2005) Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody. Nephron Exp Nephrol 99:e121-e129
9. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ (2007) A microRNA component of the p53 tumour suppressor network. Nature 447:1130-1134
10. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455:58-63
11. Krol J, Loedige I, Filipowicz W (2010) The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11:597-610
12. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105
13. Li JY, Yong TY, Michael MZ, Gleadle JM (2010) Review: the role of microRNAs in kidney disease. Nephrology (Carlton) 15:599-608
14. Lau NC, Lim LP, Weinstein EG, Bartel DP (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294:858-862
15. Welch C, Chen Y, Stallings RL (2007) MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells. Oncogene 26:5017-5022
16. Cole KA, Attiyeh EF, Mosse YP, Laquaglia MJ, Diskin SJ, Brodeur GM, Maris JM (2008) A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. Mol Cancer Res 6:735-742
17. Tazawa H, Tsuchiya N, Izumiya M, Nakagama H (2007) Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc Natl Acad Sci USA 104:15472-15477
18. Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J (2009) MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met. Invest Ophthalmol Vis Sci 50:1559-1565
19. Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R (2010) microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 9:1031-1036
20. Pang RT, Leung CO, Ye TM, Liu W, Chiu PC, Lam KK, Lee KF, Yeung WS (2010) MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells. Carcinogenesis 31:1037-1044
21. Ichimura A, Ruike Y, Terasawa K, Shimizu K, Tsujimoto G (2010) MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol 77:1016-1024
22. Sun F, Fu H, Liu Q, Tie Y, Zhu J, Xing R, Sun Z, Zheng X (2008) Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett 582:1564-1568
23. Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R (2009) MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res 69:7569-7576
24. Chen X, Qiu Q, Tang L, Liu S, Cai G, Liu H, Xie Y (2004) Effects of co-administration of urokinase and benazepril on severe IgA nephropathy. Nephrol Dial Transplant 19:852-857
25. D'Amico G (1987) The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 64:709-727
26. Julian BA, Waldo FB, Rifai A, Mestecky J (1988) IgA nephropathy, the most common glomerulonephritis worldwide. A neglected disease in the United States. Am J Med 84:129-132
27. Levy M, Berger J (1988) Worldwide perspective of IgA nephropathy. Am J Kidney Dis 12:340-347
28. Jennette JC, Wall SD, Wilkman AS (1985) Low incidence of IgA nephropathy in blacks. Kidney Int 28:944-950
29. Rambausek M, Rauterberg EW, Waldherr R, Demaine A, Krupp G, Ritz E (1987) Evolution of IgA glomerulonephritis: relation to morphology, immunogenetics, and BP. Semin Nephrol 7:370-373
30. Seedat YK, Nathoo BC, Parag KB, Naiker IP, Ramsaroop R (1988) IgA nephropathy in blacks and Indians of Natal. Nephron 50:137-141
31. Okada K, Funai M, Kawakami K, Kagami S, Yano I, Kuroda Y (1990) IgA nephropathy in Japanese children and adults: a comparative study of clinicopathological features. Am J Nephrol 10:191-197
32. Simon P, Ramee MP, Autuly V, Laruelle E, Charasse C, Cam G, Ang KS (1994) Epidemiology of primary glomerular diseases in a French region. Variations according to period and age. Kidney Int 46:1192-1198
33. Stratta P, Segoloni GP, Canavese C, Sandri L, Mazzucco G, Roccatello D, Manganaro M, Vercellone A (1996) Incidence of biopsy-proven primary glomerulonephritis in an Italian province. Am J Kidney Dis 27:631-639
34. Koyama A, Igarashi M, Kobayashi M (1997) Natural history and risk factors for immunoglobulin A nephropathy in Japan. Research Group on Progressive Renal Diseases. Am J Kidney Dis 29:526-532
35. Woo KT, Chiang GS, Pall A, Tan PH, Lau YK, Chin YM (1999) The changing pattern of glomerulonephritis in Singapore over the past two decades. Clin Nephrol 52:96-102
36. Li PK, Ho KK, Szeto CC, Yu L, Lai FM (2002) Prognostic indicators of IgA nephropathy in the Chinese-clinical and pathological perspectives. Nephrol Dial Transplant 17:64-69
37. Li LS, Liu ZH (2004) Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Kidney Int 66:920-923
38. Wei JS, Song YK, Durinck S, Chen QR, Cheuk AT, Tsang P, Zhang Q, Thiele CJ, Slack A, Shohet J, Khan J (2008) The MYCN oncogene is a direct target of miR-34a. Oncogene 27:5204-5213
39. Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X (2009) miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett 275:44-53
40. Hunter T (1993) Braking the cycle. Cell 75:839-841
41. Sherr CJ (1993) Mammalian G1 cyclins. Cell 73:1059-1065
42. Funk JO, Galloway DA (1998) Inhibiting CDK inhibitors: new lessons from DNA tumor viruses. Trends Biochem Sci 23:337-341
43. Shankland SJ, Hugo C, Coats SR, Nangaku M, Pichler RH, Gordon KL, Pippin J, Roberts JM, Couser WG, Johnson RJ (1996) Changes in cell-cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int 50:1230-1239
44. Lang S, Hartner A, Sterzel RB, Schocklmann HO (2000) Requirement of cyclin D1 in mesangial cell mitogenesis. J Am Soc Nephrol 11:1398-1408
45. Schocklmann HO, Lang S, Sterzel RB (1999) Regulation of mesangial cell proliferation. Kidney Int 56:1199-1207
46. Floege J, Eitner F, Alpers CE (2008) A new look at platelet-derived growth factor in renal disease. J Am Soc Nephrol 19:12-23
47. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R (1992) Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416
48. Liu S, Xie Y, Lv Y, Qin F, Fu B, Shi S, Yin Z, Hong Q, Zhang X, Wang J, Chang M, Chen X (2010) A novel target of mizoribine inhibiting mesangial cell proliferation: S phase kinase-associated protein 2. Am J Nephrol 32:447-455
49. Khwaja A, Sharpe CC, Noor M, Hendry BM (2006) The role of geranylgeranylated proteins in human mesangial cell proliferation. Kidney Int 70:1296-1304
50. Bokemeyer D, Panek D, Kitahara M, Trzaskos JM, Muller CE, Hockemeyer J, Kunter U, Boor P, Floege J, Kramer HJ, Ostendorf T (2007) The map kinase ERK regulates renal activity of cyclin-dependent kinase 2 in experimental glomerulonephritis. Nephrol Dial Transplant 22:3431-3441
51. Huang Y, Noble NA, Zhang J, Xu C, Border WA (2007) Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells. Kidney Int 72:45-52
52. Kato M, Arce L, Natarajan R (2009) MicroRNAs and their role in progressive kidney diseases. Clin J Am Soc Nephrol 4:1255-1266